FFA
KURA icon

Farther Finance Advisors’s Kura Oncology KURA Stock Holding History

Farther Finance Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3K Buy
1,118
+476
+74% +$4.49K ﹤0.01% 4296
2026
Q1 		$5.35K Sell
642
-863
-57% -$7.41K ﹤0.01% 4459
2025
Q4 		$15.6K Buy
1,505
+1,320
+714% +$13.8K ﹤0.01% 3601
2025
Q3 		$1.64K Buy
185
+152
+461% +$1.08K ﹤0.01% 4210
2025
Q2 		$190 Sell
33
-71
-68% -$435 ﹤0.01% 4217
2025
Q1 		$664 Buy
104
+89
+593% +$694 ﹤0.01% 3724
2024
Q4 		$131 Sell
15
-12
-44% -$173 ﹤0.01% 3743
2024
Q3 		$528 Buy
27
+12
+80% +$243 ﹤0.01% 3414
2024
Q2 		$318 Hold
15
– – ﹤0.01% 3386
2024
Q1 		$327 Hold
15
– – ﹤0.01% 3145
2023
Q4 		$216 Buy
+15
New +$147 ﹤0.01% 3213

Other funds holding KURA

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
FCC
Flower City Capital Pittsford, New York $227M AUM 23.31% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Farther Finance Advisors's KURA Position: Q2 2026 in Review

Farther Finance Advisors increased its Kura Oncology (KURA) stake by 74% in Q2 2026, buying an estimated $4.49K and bringing the position to 1,118 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4296.

Farther Finance Advisors first reported a position in KURA in Q4 2023 and has held it in 11 quarters since. The position peaked at $15.6K in Q4 2025. 25 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Farther Finance Advisors held 1,118 shares of Kura Oncology worth $12.3K as of Q2 2026.
  • Farther Finance Advisors bought 476 Kura Oncology shares in Q2 2026, an estimated $4.49K.
  • Kura Oncology made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4296 holding.
  • Farther Finance Advisors first reported a position in Kura Oncology in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Kura Oncology position peaked at $15.6K in Q4 2025.
  • 25 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.